BRD2 and metabolic syndrome: After adjusting for age, general obesity, abdominal obesity, diabetes duration, hypertension, glycemic control, dyslipidemia, hyperuricemia, LH, PRL, and estradiol, the negative association between the serum FSH level and NAFLD still remained significant (OR: 0.411, 95% CI: 0.260–0.651, p < .001).